 |
Important Legal Information
Investments are subject to investment risks, fund value may go up as well as down and past performance is not indicative of future performance. The investment returns are denominated in fund currency. Investors investing in funds denominated in non-local currency should be aware of the risk of exchange rate fluctuations that may cause a loss of principal. Investors should read carefully the Explanatory Memorandum / Prospectus (including the section "Risk Considerations") for the relevant risks associated with the investment in the fund before investing. Please contact your financial advisor if you are in doubt of any information contained in this website. This report has not been reviewed by the Securities and Futures Commission of Hong Kong.
|
|
|
 |
| Fund Details |
|
|
|
Daily Prices
|
As of 29/07/2010 |
| A(acc) |
USD |
8.72 |
| B(acc) |
USD |
7.66 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
Franklin
Biotechnology Discovery Fund |
|
|
| |
| |
| Index: Nasdaq Biotech
Index |
| |
| Investment Objective:
The Fund aims to achieve capital appreciation by investing principally in equity securities of biotechnology companies and discovery research firms mainly located in the US.
|
| |
| Fund Manager: Evan McCulloch |
| |
| Valuation: Daily |
| |
| Base Currency: US Dollars |
|